ArticleMolecular carcinogenesis2023

Targeting BRPF3 moderately reverses olaparib resistance in high grade serous ovarian carcinoma.

Benjamin G Bitler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.